# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Aditxt and Evofem amended and restated their merger agreement.
This amended and restated Merger Agreement, among others, addresses pre-closing issues critical for Evofem's future success...
- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio --- Newly issued patent...
Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a company dedicated to discovering, developing, and dep...
-8-K